1. Home
  2. TGT vs ZTS Comparison

TGT vs ZTS Comparison

Compare TGT & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Corporation

TGT

Target Corporation

HOLD

Current Price

$119.37

Market Cap

52.5B

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$113.51

Market Cap

48.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGT
ZTS
Founded
1902
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.5B
48.7B
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
TGT
ZTS
Price
$119.37
$113.51
Analyst Decision
Buy
Buy
Analyst Count
27
11
Target Price
$118.60
$156.20
AVG Volume (30 Days)
5.1M
3.5M
Earning Date
03-03-2026
05-05-2026
Dividend Yield
3.81%
1.87%
EPS Growth
N/A
10.05
EPS
8.13
6.02
Revenue
$72,618,000,000.00
$9,467,000,000.00
Revenue This Year
$2.90
$5.67
Revenue Next Year
$2.65
$4.85
P/E Ratio
$14.71
$18.84
Revenue Growth
1.88
2.28
52 Week Low
$83.44
$113.30
52 Week High
$126.00
$172.23

Technical Indicators

Market Signals
Indicator
TGT
ZTS
Relative Strength Index (RSI) 59.99 34.32
Support Level $111.90 N/A
Resistance Level $126.00 $130.52
Average True Range (ATR) 2.68 3.24
MACD -0.19 -0.29
Stochastic Oscillator 69.43 1.81

Price Performance

Historical Comparison
TGT
ZTS

About TGT Target Corporation

Target's start dates back to 1962, but now it is one of the largest discount retailers in the United States (where it derives all of its sales), operating just under 2,000 stores and generating over $106 billion in fiscal 2024 sales. The company offers a broad assortment of merchandise across categories including apparel and accessories (16% of fiscal 2024 revenue), beauty and household essentials (30%), food and beverage (23%), hardlines (15%), as well as home furnishings (16%). Target's model is anchored in its physical store base, which fulfills more than 97% of sales. Around 30% of sales are derived from its own private-label brands.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: